Can Leqvio Cause Muscle Pain?
Leqvio (inclisiran) does NOT commonly cause muscle pain and has a significantly lower risk of muscle-related adverse events compared to statins. In fact, muscle toxicity appears uncommon with PCSK9 inhibitors as a class, with overall side effect incidence similar to placebo 1.
Key Evidence on Muscle-Related Side Effects
What the Guidelines Tell Us
According to the 2022 BMJ clinical practice guideline, muscle toxicity or hepatic dysfunction seem uncommon with PCSK9 inhibitors (which includes inclisiran), and the overall incidence of side effects is similar to placebo 1. This stands in stark contrast to statins, where muscle-related adverse events account for up to 72% of all adverse events 1.
Real-World Safety Data
The most recent and comprehensive evidence comes from:
VICTORION-Difference trial (2025): This phase 4 randomized controlled trial of 1,770 patients demonstrated that fewer participants receiving inclisiran reported muscle-related adverse events (MRAEs) compared to optimized lipid-lowering therapy (11.9% vs. 19.2%; OR 0.57, p<0.001) 2. Importantly, inclisiran actually reduced pain severity and interference scores compared to the control group.
FAERS pharmacovigilance study (2024): Analysis of 4,054 adverse event reports found that musculoskeletal and connective tissue disorders represented 18.5% of reports, with myalgia (muscle pain) identified as one of the more commonly reported symptoms 3. However, the most prominent adverse events were injection site reactions (24.9%), not systemic muscle pain.
Clinical Implications
What You Should Tell Patients
- Muscle pain is NOT a characteristic side effect of Leqvio unlike statins
- The most common side effects are injection site reactions (pain, erythema, allergic effects at the injection site) 1, 3
- If muscle pain occurs, it's likely unrelated to inclisiran or may be coincidental
Important Caveats
- Do not automatically attribute muscle pain to inclisiran - investigate other causes first
- The drug has been studied for relatively short periods (long-term safety beyond 3 years requires further investigation) 1
- Inclisiran may be an excellent alternative for patients with statin-associated muscle symptoms who need additional LDL-C lowering 2
Other Notable Side Effects to Monitor
According to the FAERS database, the most common adverse events are 3:
- Injection site pain (most common)
- Myalgia (muscle pain - but much less common than with statins)
- Gastrointestinal disorders (8.7% of reports)
Bottom line: Leqvio is remarkably well-tolerated regarding muscle symptoms and represents a safer alternative to statins for patients concerned about or experiencing muscle-related adverse events.